[1] Bajaj J S,O′Leary J G,Lai J C,et al.Acute-on-chronic liver failure clinical Guidelines[J]. Am J Gastroenterol,2022,117(2):225-252. [2] Mezzano G,Juanola A,Cardenas A,et al.Global burden of disease: acute-on-chronic liver failure,a systematic review and meta-analysis[J]. Gut,2022,71(1):148-155. [3] Bai C Z,Ren J,Zhang X,et al.Global acute-on-chronic liver failure trends during 2012-2022:a bibliometric study[J]. Heliyon,2024,10(3):e25791. [4] Kulkarni A V,Gustot T,Reddy K R.Liver transplantation for acute liver failure and acute-on-chronic liver failure[J]. Am J Transplant,2024,24(11):1950-1962. [5] Liu L,Huang C,Nie Y,et al.Low platelet to high-density lipoprotein ratio predicts poor short-term prognosis in hepatitis B-related acute-on-chronic liver failure[J]. BMC Infect Dis,2024,24(1):888. [6] 司诺,刘芳,刘磊,等.PLT水平及PLT参数对慢加急性肝衰竭患者预后的影响[J]. 临床肝胆病杂志,2022,38(2):381-386. [7] 中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南(2018年版)[J]. 实用肝脏病杂志,2019,22(2):164-171. [8] Zou J,Li H,Deng G,et al.A novel prognostic nomogram for older patients with acute-on-chronic liver diseases(AoCLD):a nationwide,multicentre,prospective cohort study[J]. Age Ageing,2023,52(1):afac313. [9] 高冉冉,曹阳,郑嵘炅,等.乙肝相关慢加急性肝衰竭患者6个月预后影响因素分析及模型构建[J]. 新疆医科大学学报,2024,47(2):209-215. [10] 韩怡然,徐开林,乔建林,等.蛋白酪氨酸磷酸酶调控血小板功能的研究现状[J]. 国际输血及血液学杂志,2024,47(1):16-22. [11] 江丽萍,陈阮琴,陈明胜.纤维蛋白原是影响HBV相关慢加急性肝衰竭近期预后的独立危险因素[J]. 肝脏,2020,25(10):1090-1093. [12] 崔秋敏,孙小鸽,马宁,等.血小板最大聚集率对脓毒性休克及脓毒性休克合并DIC的预测价值[J]. 中华危重病急救医学,2023,35(3):238-243. [13] Protti A,Fortunato F,Artoni A,et al.Platelet mitochondrial dysfunction in critically ill patients:comparison between sepsis and cardiogenic shock[J]. Crit Care,2015,19(1):39. [14] 韩文秀,荀运浩,过建春,等.附子联合对乙酰氨基酚诱导小鼠急性肝衰竭阴虚模型的研究[J]. 中华中医药杂志,2023,38(6):2555-2560. |